Key Team Members
Thomas Ball, PhD
Founder & Chief Executive Officer
Thomas Ball is the Founder and CEO of The Reflux Company and an experienced medical device executive with a track record of commercializing reflux technologies across international markets. He founded The Reflux Company in 2025 to build a comprehensive platform spanning the diagnosis, management, and treatment of reflux disease and leads the Company's strategy, acquisitions, global commercialization, and growth.
Joel Uckelman, PhD
Chief Software Engineer
Joel Uckelman is a technology executive with a background in computer science, cybersecurity, and complex technical systems. At The Reflux Company, he brings technology and operational expertise to the senior leadership team, supporting the systems and infrastructure required to scale the Company's growing reflux-focused platform.
Mark Clark, CPA
Chief Financial Officer
Mark Clark is a seasoned financial executive and Certified Public Accountant with extensive experience in middle-market companies, international operations, and corporate growth. His career includes 15 years on the senior leadership team of a private-equity-backed company that grew from approximately $100 million in revenue to more than $1.5 billion, giving him deep expertise in finance, strategy, operational scale, and value creation.
Lauren Mierke
Director of Marketing
Lauren Mierke is an experienced medical device sales and marketing professional with more than two decades of healthcare industry experience and a longstanding focus on reflux diagnostics. Before becoming Director of Marketing at The Reflux Company, she held sales, regional management, customer success, and marketing roles at Restech and other medical device companies, bringing extensive knowledge of clinicians, customers, and the reflux market.
Bobby Gaglione
Operations Manager
Bobby Gaglione oversees The Reflux Company's operational and technical activities as the Company expands its medical device portfolio and prepares products for commercialization. He has two decades of manufacturing experience, is a member of the Association of Supply Chain Management, and has extensive Lean & 6σ experience.
Board Members
Shaun O’Neil
Shaun O’Neil is President and Chief Operating Officer of Lucid Diagnostics and brings extensive experience across medical devices, diagnostics, digital health, sales, marketing, and market access. He has led the commercialization of innovative diagnostic technologies and brings a strong track record of building commercial organizations and launching new healthcare products.
Bert Sutter
Bert Sutter is CEO of Sutter Medizintechnik and a veteran medical technology executive with more than 30 years of leadership experience in the global MedTech industry. He has overseen the international commercialization of innovative medical technologies in more than 50 countries and brings extensive experience in manufacturing, product development, intellectual property, and global market expansion.
Richard Mockler
Richard Mockler is a healthcare executive, advisor, and investor with extensive experience in strategy, growth, payer engagement, and healthcare innovation. His previous leadership roles include SVP of New Markets and Innovation for UnitedHealth Group's Specialty Networks business and Chief Growth Officer of Sanvello, bringing valuable expertise in market access, policy, strategic sales, and emerging healthcare technologies.
Daniel Capuano
Daniel Capuano is CEO of the MedStent Group, with 30+ years experience in commercialization, market growth, and distribution in Latin America. He has played an important role introducing innovative medical technologies throughout the region, including the commercialization, launch, and distribution of the Stretta procedure.
